利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

1469 条记录 (耗时 0.063 秒)

    Treatment indications informed by a priori implant information
    5.
    发明申请
    Treatment indications informed by a priori implant information 审中-公开
    治疗指征通过先验植入物信息通知

    公开(公告)号：US20090157171A1

    公开(公告)日：2009-06-18

    申请号：US12005154

    申请日：2007-12-21

    申请人： Bran Ferren ,  Roderick A. Hyde ,  Muriel Y. Ishikawa ,  Eric C. Leuthardt ,  Dennis J. Rivet ,  Lowell L. Wood, JR. ,  Victoria Y.H. Wood

    发明人： Bran Ferren ,  Roderick A. Hyde ,  Muriel Y. Ishikawa ,  Eric C. Leuthardt ,  Dennis J. Rivet ,  Lowell L. Wood, JR. ,  Victoria Y.H. Wood

    IPC分类号： A61F2/06

    CPC分类号： A61M39/24 ,  A61B5/145 ,  A61M5/14276 ,  A61M31/00 ,  A61M2005/1726 ,  A61M2039/2413 ,  A61M2039/242 ,  A61M2039/248 ,  A61M2205/04 ,  A61M2205/3561 ,  A61M2205/3592 ,  G06F19/3468

    摘要： Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lactic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature.

    摘要翻译： 描述了用于实现或部署用于获得先验植入物信息并发出决定是否是基于先验植入物信息并且部分基于一个或多个其他凝块指示的启动植入位点靶向治疗的决定的系统和方法 决定因素 或获得指示流量变化的测量，并且至少部分地基于所述流变指示测量来发信号通知是否施用一种或多种凝块减少剂的决定; 或者在一个或多个体腔附近获得一种或多种乳酸物质的指示，并通过使一种或多种元素在一个或多个体腔内提取而加速在一个或多个体腔附近的溶解物质的局部浓度的降低 响应于在一个或多个体腔附近的溶解材料的一个或多个指示，一个或多个体腔附近的溶解材料的至少一部分; 或一个或多个捕获组分，其配置成加速沿着脉管系统的下游部分的一个或多个治疗结构的局部浓度的降低以及被配置为将一个或多个治疗结构释放到脉管系统的上游部分中的一个或多个分配组分 。

    Treatment indications informed by a priori implant information
    6.
    发明申请
    Treatment indications informed by a priori implant information 有权
    治疗指征通过先验植入物信息通知

    公开(公告)号：US20090157054A1

    公开(公告)日：2009-06-18

    申请号：US12004107

    申请日：2007-12-18

    申请人： Bran Ferren ,  Roderick A. Hyde ,  Muriel Y. Ishikawa ,  Eric C. Leuthardt ,  Dennis J. Rivet ,  Lowell L. Wood, JR. ,  Victoria Y.H. Wood

    发明人： Bran Ferren ,  Roderick A. Hyde ,  Muriel Y. Ishikawa ,  Eric C. Leuthardt ,  Dennis J. Rivet ,  Lowell L. Wood, JR. ,  Victoria Y.H. Wood

    IPC分类号： A61M5/142

    CPC分类号： A61M39/24 ,  A61B5/145 ,  A61M5/14276 ,  A61M31/00 ,  A61M2005/1726 ,  A61M2039/2413 ,  A61M2039/242 ,  A61M2039/248 ,  A61M2205/04 ,  A61M2205/3561 ,  A61M2205/3592 ,  G06F19/00 ,  G06F19/3468

    摘要： Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature.

    摘要翻译： 描述了用于实现或部署用于获得先验植入物信息并发出决定是否是基于先验植入物信息并且部分基于一个或多个其他凝块指示的启动植入位点靶向治疗的决定的系统和方法 决定因素 或获得指示流量变化的测量，并且至少部分地基于所述流变指示测量来发信号通知是否施用一种或多种凝块减少剂的决定; 或获得在一个或多个体腔附近的溶解材料的一个或多个指示，并通过使一个或多个元件在一个或多个体腔内提取而加速在一个或多个体腔附近的溶解物质的局部浓度的降低 响应于在一个或多个体腔附近的溶解材料的一个或多个指示，一个或多个体腔附近的溶解材料的至少一部分; 或一个或多个捕获组分，其配置成加速沿着脉管系统的下游部分的一个或多个治疗结构的局部浓度的降低以及被配置为将一个或多个治疗结构释放到脉管系统的上游部分中的一个或多个分配组分 。